Clinical trials
Myelodysplastic Syndromes trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
110 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 7 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 2 |
| 2013 | 4 |
| 2014 | 11 |
| 2015 | 7 |
| 2016 | 8 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 7 |
| 2022 | 7 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 54 |
| Terminated | 19 |
| Recruiting | 13 |
| Unknown status | 13 |
| Active, not recruiting | 7 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 13 |
| Novartis Pharmaceuticals | 10 |
| Kiadis Pharma | 5 |
| King's College Hospital NHS Trust | 5 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| GlaxoSmithKline | 3 |
| Janssen Research & Development, LLC | 3 |
| Pfizer | 3 |
| Takeda | 3 |
| University College, London | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 110 |
| Leukemia, Myeloid, Acute | 59 |
| Leukemia | 22 |
| Leukemia, Myelomonocytic, Chronic | 21 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 16 |
| Hematologic Neoplasms | 12 |
| Anemia, Refractory, with Excess of Blasts | 11 |
| Anemia | 10 |
| Myeloproliferative Disorders | 9 |
| Graft vs Host Disease | 8 |
Trials
Showing 26 to 50 of 110. Each trial links to its page on Pharma Observatory.
10 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.